Skip to content

Medical emergency? What to do

Link Between Obesity and Inflammation Could Lead to New Therapies

3-RXPublished November 16, 20063 min read

Key points

  • Research conducted at the Methodist DeBakey Heart Center in Houston identifies a molecular link between obesity and inflammation that could lead to new therapies to prevent diabetes and heart disease.
  • “Understanding this link between obesity, diet and inflammation, may help us preventdiabetes and heart disease by tailoring new therapies to block the inflammation that initiates the destructive process,” said Dr.
  • “The results of these studies provide additional evidence that new therapies which block the initial inflammation in fat tissue may help prevent or treat disorders related to obesity such as diabetes and heart disease,” Ballantyne said.
  • For more information on the Methodist DeBakey Heart Center, see http://www.debakeyheartcenter.com.

Research conducted at the Methodist DeBakey Heart Center in Houston identifies a molecular link between obesity and inflammation that could lead to new therapies to prevent diabetes and heart disease.

Research presented this week at the American Heart Association Scientific Sessions shows that a high fat diet draws inflammatory cells into fat tissue, which prevents the tissue from storing the fats we eat. When the tissue can not store these fats, they end up in the liver and muscle, which in turn causes diabetes and heart disease.

“Understanding this link between obesity, diet and inflammation, may help us preventdiabetes and heart disease by tailoring new therapies to block the inflammation that initiates the destructive process,” said Dr. Christie Ballantyne, cardiologist at the Methodist DeBakey Heart Center and principal investigator for the research.

Research presented today shows that a high fat diet leads fat cells to produce molecules called chemokines, which attract inflammatory white blood cells into fat tissue. Both macrophages and T cells , which play a critical role in the immune system, accumulate in fat tissue, beginning the process that leads to disease.

“The results of these studies provide additional evidence that new therapies which block the initial inflammation in fat tissue may help prevent or treat disorders related to obesity such as diabetes and heart disease,” Ballantyne said.

This research was funded jointly by the American Diabetes Association and a grant from the Methodist DeBakey Heart Center.

For more information on the Methodist DeBakey Heart Center, see http://www.debakeyheartcenter.com.

Study detail
Obesity is associated with chronic inflammation, evidenced by elevated cytokine and chemokine expression and increased macrophage accumulation in adipose (fat) tissue (AT). T cells also play an important role in chronic inflammatory diseases such as atherosclerosis but have not been well studied in obesity. The study hypothesized that elevated chemokines levels in AT in obesity are also associated with increased T cell accumulation.

Using flow cytometry, the study examined T cells in stromal/vascular cells from AT of diet-induced obese mice, which were C57BL/6 fed western high-fat diet 24 wk.

Compared to lean controls on standard chow diet, obese male mice but not obese females had significantly increased T cell number in AT (CD3+ cells: 3.5±0.4 x105/g tissue in obese males vs 1.5 ± 0.2 x105/g tissue in leans, P<0.01, n=5/group). mRNA levels of MCP-1, RANTES, and their receptors, CCR2 and CCR5, were upregulated in AT of obese males as examined by RNase protection assay (relative intensity to GAPDH and L32: MCP-1, 689±63 vs 188±6 in lean, P<0.01; RANTES, 558±84 vs 171±18, P<0.05; CCR2, 137±8 vs 63±4, P<0.01; CCR5, 135±13 vs 34±1, P<0.01; n=4/group).

AT from obese males also secreted higher levels of MCP-1 and RANTES than AT from lean controls when cultured ex vivo for 8 hr (MCP-1, 247±28 vs 133±14 ng/g tissue in lean, P<0.05; RANTES, 1716±133 vs 537±101 pg/g tissue in lean, P<0.01; n=4/group).

In vitro chemotaxis study showed that conditioned culture medium from AT of obese males induced significantly more T cell transmigration than AT of lean controls (448±90 vs 104±22 in lean, P<0.05, n=3/group).

Antibody neutralization of RANTES or MCP-1 markedly inhibited T cell transmigration induced by conditioned medium from AT of obese males (RANTES, inhibition 51±8%, P<0.05; MCP-1, inhibition 74±4%, P<0.05; n=3). In addition, mRNA levels of MCP-1, RANTES, CCR2 and CCR5 were increased in visceral AT compared to subcutaneous AT from morbidly obese humans.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underObesity

Keep reading

Obesity

Grant targeting obesity awarded to HealthNet

The New York State Department of Health awarded a five-year grant to Herkimer County HealthNet, Inc. to establish programs to prevent obesity, type 2 diabetes and other chronic diseases in Herkimer County. The grant…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.